SCHEMBL19488554

SCHEMBL19488554

CCCNCc1nc2ccc(-c3ccc(-c4ccc(-c5cnc([C@@H]6CCCN6)[nH]5)cc4)cc3)cc2[nH]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN10A Q9Y5Y9 2/20 0.40
AAK1 Q2M2I8 6/20 0.39
ROCK2 O75116 1/20 0.32
MELK Q14680 1/20 0.32
SSTR3 P32745 4/20 0.32
CACNA1B Q00975 1/20 0.31
TGFBR1 P36897 1/20 0.31
HRH4 Q9H3N8 1/20 0.30
HRH3 Q9Y5N1 1/20 0.30
SSTR4 P31391 2/20 0.30
SSTR5 P35346 2/20 0.30
MAPK13 O15264 1/20 0.30
MAPK12 P53778 1/20 0.30
MAPK11 Q15759 1/20 0.30
MAPK14 Q16539 1/20 0.30
CACNA1F O60840 1/20 0.30
SSTR1 P30872 1/20 0.30
CACNA1D Q01668 1/20 0.30
KCNH2 Q12809 1/20 0.30
CACNA1S Q13698 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19488473 0.94 SCN10A (0.39) SCN10AAAK1ROCK2MELKSSTR3
SCHEMBL19488306 0.89 SCN10A (0.39) SCN10AAAK1ROCK2MELKCACNA1B
SCHEMBL19488293 0.89 AAK1 (0.37) SCN10AAAK1
SCHEMBL19488295 0.89 AAK1 (0.37) SCN10AAAK1SSTR3
SCHEMBL19488290 0.87 SCN10A (0.37) SCN10AAAK1ROCK2MELKCACNA1B
SCHEMBL11982065 0.86 SSTR3 (0.36) SCN10ASSTR3SSTR4SSTR5MAPK13
SCHEMBL20221011 0.86 SSTR3 (0.36) SCN10ASSTR3SSTR4SSTR5MAPK13
SCHEMBL19488471 0.84 SCN10A (0.40) SCN10AAAK1HRH4HRH3
SCHEMBL19339890 0.82 NR1H4 (0.34) SCN10ASSTR3MAPK13MAPK12MAPK11
SCHEMBL13192596 0.81 SCN10A (0.56) SCN10AAAK1MAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2601188-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-10-18 EP disclosed